Idelalisib sensitivity and mechanisms of disease progression in relapsed TCF3-PBX1 acute lymphoblastic leukemia

Show full item record



Permalink

http://hdl.handle.net/10138/194786

Citation

Eldfors , S , Kuusanmäki , H , Kontro , M , Majumder , M M , Parsons , A , Edgren , H , Pemovska , T , Kallioniemi , O , Wennerberg , K , Gökbuget , N , Burmeister , T , Porkka , K & Heckman , C A 2017 , ' Idelalisib sensitivity and mechanisms of disease progression in relapsed TCF3-PBX1 acute lymphoblastic leukemia ' , Leukemia , vol. 31 , no. 1 , pp. 51-57 . https://doi.org/10.1038/leu.2016.202

Title: Idelalisib sensitivity and mechanisms of disease progression in relapsed TCF3-PBX1 acute lymphoblastic leukemia
Author: Eldfors, S.; Kuusanmäki, H.; Kontro, M.; Majumder, M. M.; Parsons, Alun; Edgren, H.; Pemovska, T.; Kallioniemi, O.; Wennerberg, K.; Gökbuget, N.; Burmeister, T.; Porkka, K.; Heckman, C. A.
Contributor organization: Institute for Molecular Medicine Finland
Clinicum
Hematologian yksikkö
Department of Oncology
Department of Medicine
Olli-Pekka Kallioniemi / Principal Investigator
Krister Wennerberg / Principal Investigator
HUS Comprehensive Cancer Center
Precision Systems Medicine
Date: 2017
Language: eng
Number of pages: 7
Belongs to series: Leukemia
ISSN: 0887-6924
DOI: https://doi.org/10.1038/leu.2016.202
URI: http://hdl.handle.net/10138/194786
Subject: 3122 Cancers
Peer reviewed: Yes
Rights: cc_by_nc_sa
Usage restriction: openAccess
Self-archived version: publishedVersion


Files in this item

Total number of downloads: Loading...

Files Size Format View
leu2016202a.pdf 1.450Mb PDF View/Open

This item appears in the following Collection(s)

Show full item record